Inventor
Luc Roland DESNOYERS
Inventor
US
Overview
Patents· 9 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides30%
A61KPreparations for medical, dental or toiletry purposes27%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
G01NInvestigating or analysing materials by determining their chemical or physical properties20%
B01DSeparation3%
PatentTitleYear
12,502,439—202512,498,367Methods of qualitatively and/or quantitatively analyzing properties of activatable antibodies and uses thereof202512,139,543Method of using an anti-epidermal growth factor receptor (EGFR) activatable antibody to detect the presence or absence of a cleaving agent and EGFR202411,992,528Compositions and methods for conjugating activatable antibodies202411,890,354Activatable antibodies that bind epidermal growth factor receptor and methods thereof202411,753,466Anti-CD166 antibodies, activatable anti-CD166 antibodies, and methods of use thereof202311,267,896Anti-CD71 antibodies, activatable anti-CD71 antibodies, and methods of use thereof202211,220,544Anti-CD166 antibodies and uses thereof202211,180,562Method of treating or delaying progression of an epidermal growth factor receptor (EGFR)-related disorder by administering activatable EGFR-binding antibodies2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2025Patents assigned to CYTOMX THERAPEUTICS INC (9)· patent assignee history
2021–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CYTOMX THERAPEUTICS INC | 9 | 2021–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 9 | 2021–2025 |